Company Overview and News

 
Yowie Group to release animation series based on Yowie characters

2018-04-03 proactiveinvestors.com.au
Yowie Group Ltd (ASX:YOW) (OTC ADR:YWRPY) has partnered with Icon Animation for a series of short animations based on the Yowie characters Rumble, Nap, Squish, Boof, Ditty and Crag.
Upvote Downvote

 
Yowie Group releases Ranger Series into Woolworths stores

2018-02-20 proactiveinvestors.com.au
Yowie Group Ltd (ASX:YOW) has released the much anticipated Ranger Series into Woolworths stores in Australia.
Upvote Downvote

 
Yowie tumbles on US competition

2018-02-14 businessnews.com.au
Shares in chocolate retailer Yowie Group dropped 21 per cent today after the company announced sales in the United States so far this quarter have been well down on expectations thanks to growing competition.
Upvote Downvote

 
Yowie drops on US competition

2018-02-14 businessnews.com.au
Shares in chocolate retailer Yowie Group dropped 21 per cent today after the company announced sales in the United States so far this quarter have been well down on expectations thanks to growing competition.
Upvote Downvote

1
Resources stocks lift as ASX grapples with low summer volumes

2018-01-03 theage.com.au
The Australian sharemarket rose for the first session in three, led by materials and energy stocks which were buoyed by a rally in commodity prices.
Upvote Downvote

1
Resources stocks lift as ASX grapples with low summer volumes

2018-01-03 smh.com.au
The Australian sharemarket rose for the first session in three, led by materials and energy stocks which were buoyed by a rally in commodity prices.
Upvote Downvote

1
Yowie stocks plunge 33pc after massive sales downgrade

2018-01-03 abc.net.au
Yowie Group's shares have plunged by more than 33 per cent, making it Australia's worst-performing stock on Wednesday.
Upvote Downvote

 
Yowie shares slump after guidance slashed

2018-01-03 businessnews.com.au
Yowie Group shares have slumped to a near-five-year low after the confectionery maker slashed its full-year sales guidance and replaced its chief executive.
Upvote Downvote

 
Yowie Group looks for fresh start with key appointment

2018-01-03 proactiveinvestors.com.au
Yowie Group Ltd (ASX:YOW) has appointed its head of North American operations and global chief operating officer Mark Schuessler as its new global chief executive officer.
Upvote Downvote

 
ASX finishes 2017 with 7pc yearly gain

2017-12-29 theage.com.au
The Australian sharemarket advanced 7.1 per cent in 2017, posting its second straight annual rise, supported by commodity producers and high-flying growth stocks.
Upvote Downvote

 
ASX finishes 2017 with 7pc yearly gain

2017-12-29 smh.com.au
The Australian sharemarket advanced 7.1 per cent in 2017, posting its second straight annual rise, supported by commodity producers and high-flying growth stocks.
Upvote Downvote

 
Yowie's shares halted pending revenue guidance

2017-12-28 proactiveinvestors.com.au
Yowie Group Ltd's (ASX:YOW) shares are in pre-open this morning, following the ASX granting the company a trading halt.
Upvote Downvote

 
YOWIE Chocolate Launches 'Rescue Series' And Pledges To Donate $25,000 To The Wildlife Conservation Society Continuing Their Efforts To Save The Natural World

2017-09-25 prnewswire
NEW YORK, Sept. 25, 2017 /PRNewswire/ -- YOWIE Group LTD. (YOWIE) announced their 'Rescue Series' chocolate line today in partnership with the Wildlife Conservation Society (WCS), demonstrating their shared commitment to encourage wildlife education and conservation. YOWIE Group's Rescue Series will contribute $25,000 to support WCS's global conservation program and will feature WCS's logo on its packaging.
Upvote Downvote

 
Edison Issues ADR Update on Yowie Group (YWRPY)

2017-09-22 accesswire
LONDON, UK / ACCESSWIRE / September 22, 2017 / After a year of internal and external challenges, we believe Yowie (OTC PINK: YWRPY) (OTC PINK: YWGRF) has built a strong and reliable operational base and business plan that will support continued sales growth and a move to profitability by the end of fiscal 2018. With US$1.25/ADR in cash, no debt, and modest working investment needs, we see Yowie shares as compelling value for long-term growth investors.
Upvote Downvote

 
Finance news you need to know today

2017-06-21 perthnow.com.au
THE Australian market looks set to open higher despite Wall Street’s Dow and S&P 500 closing lower, pulled down by another sharp fall in oil prices. At 0700 AEST on Thursday, the share price futures index was up 18 points, or 0.32 per cent, at 5,622.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...